Vistagen Therapeutics, Inc. (VTGN)
NASDAQ: VTGN · Real-Time Price · USD
0.5300
+0.0244 (4.83%)
At close: Feb 17, 2026, 4:00 PM EST
0.5200
-0.0100 (-1.89%)
After-hours: Feb 17, 2026, 7:45 PM EST
Vistagen Therapeutics Employees
Vistagen Therapeutics had 59 employees as of September 30, 2025. The number of employees increased by 14 or 31.11% compared to the same quarter last year.
Employees
59
Change
14
Growth
31.11%
Revenue / Employee
$13,373
Profits / Employee
-$1,136,373
Market Cap
21.00M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Sep 30, 2025 | 59 | 14 | 31.11% | 59 | 0 |
| Jun 30, 2025 | 57 | 16 | 39.02% | 57 | 0 |
| Mar 31, 2025 | 57 | 17 | 42.50% | 56 | 1 |
| Dec 31, 2024 | 48 | 11 | 29.73% | 48 | 0 |
| Sep 30, 2024 | 45 | 12 | 36.36% | 45 | 0 |
| Jun 30, 2024 | 41 | 9 | 28.13% | 41 | 0 |
| Mar 31, 2024 | 40 | 6 | 17.65% | 39 | 1 |
| Dec 31, 2023 | 37 | 5 | 15.63% | 37 | 0 |
| Sep 30, 2023 | 33 | -1 | -2.94% | 33 | 0 |
| Jun 30, 2023 | 32 | -6 | -15.79% | 32 | 0 |
| Mar 31, 2023 | 34 | -2 | -5.56% | 33 | 1 |
| Dec 31, 2022 | 32 | 1 | 3.23% | 32 | 0 |
| Sep 30, 2022 | 34 | 8 | 30.77% | 34 | 0 |
| Jun 30, 2022 | 38 | 14 | 58.33% | 38 | 0 |
| Mar 31, 2022 | 36 | 15 | 71.43% | 36 | 0 |
| Dec 31, 2021 | 31 | 20 | 181.82% | 31 | 0 |
| Sep 30, 2021 | 26 | 17 | 188.89% | 26 | 0 |
| Jun 30, 2021 | 24 | 15 | 166.67% | 24 | 0 |
| Mar 31, 2021 | 21 | 12 | 133.33% | 21 | 0 |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Sep 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Jun 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Sep 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Jun 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Sep 30, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Jun 30, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Sep 30, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Jun 30, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Mar 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
Related Stocks
| Company Name | Employees |
|---|---|
| CASI Pharmaceuticals | 233 |
| Senti Biosciences | 34 |
| Serina Therapeutics | 13 |
| Genenta Science | 13 |
| VYNE Therapeutics | 13 |
| Neuphoria Therapeutics | 8 |
| NanoViricides | 7 |
| Phio Pharmaceuticals | 5 |
VTGN News
- 5 days ago - Vistagen Therapeutics, Inc. (VTGN) Q3 2026 Earnings Call Transcript - Seeking Alpha
- 5 days ago - Vistagen Reports Fiscal Year 2026 Third Quarter Financial Results and Provides Corporate Update - Business Wire
- 8 days ago - UPCOMING DEADLINE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Vistagen Therapeutics - Newsfile Corp
- 11 days ago - VTGN Investors Encouraged to Seek Lead Plaintiff Role in Vistagen Therapeutics Securities Class Actoin Case with Johnson Fistel - GlobeNewsWire
- 13 days ago - Vistagen to Report Fiscal Year 2026 Third Quarter Results and Host Corporate Update Conference Call on February 12, 2026 - Business Wire
- 19 days ago - INVESTOR NOTICE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Vistagen Therapeutics - PRNewsWire
- 26 days ago - VISTAGEN THERAPEUTICS, INC. (NASDAQ: VTGN) DEADLINE ALERT – Bernstein Liebhard LLP Reminds Vistagen Therapeutics, Inc. Investors of Upcoming Deadline - GlobeNewsWire
- 4 weeks ago - VISTAGEN THERAPEUTICS, INC. (NASDAQ: VTGN) INVESTOR ALERT Investors With Large Losses in Vistagen Therapeutics, Inc. Should Contact Bernstein Liebhard LLP To Discuss Their Rights - GlobeNewsWire